As a partner of Cambridge Healthcare Research, Max is responsible for company growth and business development. He also heads CHR’s Rare Diseases division, supporting client product strategy in over a dozen rare diseases.
Max is an experienced consultant with a broad background in strategic consulting and the pharmaceutical industry. He has led projects supporting pharmaceutical and biotech companies in a wide range of commercial strategy issues, including forecasting, market assessments, competitive threat analysis and launch planning. Max’s client work has encompassed multiple therapeutic areas, amongst them neurology, endocrinology, haematology, vaccines and regenerative medicine.
Max holds an MBA from the University of Cambridge and a BSc in Biotechnology from Tel Aviv University. Prior to CHR, he was a Senior Consultant and Engagement Manager at a life science consultancy, and a Project Manager at Teva Pharmaceuticals.
In his free time, Max enjoys running along the river Cam (and through the green parts of any city business travel brings him to), camping with his wife and two boys, and listening to alternative rock.